Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
10/15/2013 | US8557322 Preparation of canola protein isolate and use in aquaculture |
10/15/2013 | US8557256 Treatment for cervical dystonia with the neurotoxic component of a botulinum toxin |
10/15/2013 | US8557246 Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof |
10/15/2013 | US8557244 Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody |
10/15/2013 | US8557242 ERBB2 antibodies comprising modular recognition domains |
10/15/2013 | US8557238 EG-VEGF nucleic acids and polypeptides and methods of use |
10/15/2013 | US8557232 Stabilization of Fc-interferon-beta fusion proteins |
10/15/2013 | CA2685350C Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents |
10/15/2013 | CA2673085C Transferrin fusion protein libraries |
10/15/2013 | CA2652450C Modified bacteriocins and methods for their use |
10/15/2013 | CA2589951C Method for producing carboxy-terminal amidated peptides |
10/15/2013 | CA2573702C Vaccine constructs and combination of vaccines designed to improve the breadth of the immune response to diverse strains and clades of hiv |
10/15/2013 | CA2555013C Carcinoembryonic antigen fusions and uses thereof |
10/15/2013 | CA2521946C Method of identifying transmembrane protein-interacting compounds |
10/15/2013 | CA2494844C Methods and compositions concerning poxviruses and cancer |
10/15/2013 | CA2483602C Fgf variants and methods for use thereof |
10/15/2013 | CA2452119C Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
10/15/2013 | CA2410762C Feline hepatocyte growth factor |
10/15/2013 | CA2402214C T1r taste receptors and genes encoding same |
10/15/2013 | CA2380108C Recombinant rsv virus expression systems and vaccines |
10/15/2013 | CA2373721C Compounds that bind her2 |
10/15/2013 | CA2367856C Analogs of gastric inhibitory peptide and their use for treatment of diabetes |
10/15/2013 | CA2330178C Synthetic peptide vaccines for foot-and-mouth disease |
10/15/2013 | CA2296434C Mutations in the myostatin gene cause double-muscling in mammals |
10/10/2013 | WO2013152274A1 Epitope- scaffold immunogens against respiratory syncytial virusm (rsv) |
10/10/2013 | WO2013152264A2 Proteins toxic to hemipteran insect species |
10/10/2013 | WO2013152076A1 Compositions and methods for treating hypertension |
10/10/2013 | WO2013152026A1 Use of apolipoprotein a-1 for promoting bone formation |
10/10/2013 | WO2013151938A1 Methods for improving diaphragm function |
10/10/2013 | WO2013151767A1 Therapy for kidney disease and/or heart failure by intradermal infusion |
10/10/2013 | WO2013151766A1 Therapy for kidney disease and/or heart failure by intradermal infusion |
10/10/2013 | WO2013151764A1 Methods and compositions for dengue virus epitopes |
10/10/2013 | WO2013151568A1 Methods of treatment with arginine deiminase |
10/10/2013 | WO2013151490A1 Methods and compounds for treating diseases |
10/10/2013 | WO2013150680A1 Protein tag, tagged protein, and protein purification method |
10/10/2013 | WO2013150532A1 Lipopeptide conjugates comprising sphingolipid and hiv gp41 derived peptides |
10/10/2013 | WO2013150518A1 Extracellular matrix metalloproteinase inducer (emmprin) peptides and binding antibodies |
10/10/2013 | WO2013150450A1 Hcv homolog fragments, cell-lines and applications thereof |
10/10/2013 | WO2013150402A1 Plants having one or more enhanced yield-related traits and method for making same |
10/10/2013 | WO2013150401A1 Plants having one or more enhanced yield-related traits and method for making same |
10/10/2013 | WO2013150400A1 Plants having one or more enhanced yield-related traits and method for making same |
10/10/2013 | WO2013150338A1 Stapled cell penetrating peptides for intracellular delivery of molecules |
10/10/2013 | WO2013150309A1 Clostridium difficile antigens |
10/10/2013 | WO2013150069A1 Improved galactose isomerases and use thereof in the production of tagatose |
10/10/2013 | WO2013149941A1 Nucleic acid sequences and peptides/ proteins of the ft family providing flower-repressing properties in tobacco and transgenic plants transformed therewith |
10/10/2013 | WO2013149801A1 Fungal resistant plants expressing hydrophobin |
10/10/2013 | WO2013149729A2 Proinsulin with enhanced helper sequence |
10/10/2013 | WO2013149526A1 Multi-functional antibody polypeptide for cryptic epitope of epidermal growth factor receptor and t cell antigen |
10/10/2013 | WO2013149334A1 Recombinant papaya mosaic virus coat proteins and uses thereof in influenza vaccines |
10/10/2013 | WO2013121441A3 Synthetic peptides capable of binding to influenza hemagglutinin protein |
10/10/2013 | WO2013114363A8 Antimicrobial agents |
10/10/2013 | WO2013098858A3 A novel insecticidal chitinase protein its encoding nucleotide and application thereof |
10/10/2013 | WO2013098852A3 Allium fistulosum leaf agglutinin rcombinant protein, its encoding polynucleotide, primer and process for preparation thereof |
10/10/2013 | WO2013097022A3 Recombinant proteins, polynucleotides and vaccines to combat bovine herpesvirus |
10/10/2013 | WO2013096732A3 Methods of treating or preventing viral diseases by blocking interleukin-21 |
10/10/2013 | WO2012107747A8 Antigenic gly1 polypeptides |
10/10/2013 | US20130269065 Blackleg resistance gene |
10/10/2013 | US20130269060 Proteins Toxic To Hemipteran Insect Species |
10/10/2013 | US20130267685 B7-H3 and B7-H4, Novel Immunoregulatory Molecules |
10/10/2013 | US20130267682 Dragline protein |
10/10/2013 | US20130267677 Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit |
10/10/2013 | US20130267676 Artificial antibody polypeptides |
10/10/2013 | US20130267468 Factor viii glycoforms |
10/10/2013 | US20130267466 Treatment Of Bleeding With Low Half-Life Fibrinogen |
10/10/2013 | US20130267465 Collagenous material |
10/10/2013 | US20130267464 Therapeutic use of a growth factor, metrnl |
10/10/2013 | US20130267458 Compositions and uses of materials with high antimicrobial activity and low toxicity |
10/10/2013 | US20130267457 Peptide inhibitors of protein synthesis |
10/10/2013 | US20130267040 Peptide capable for binding to rhodium |
10/10/2013 | US20130267028 Recombinant Influenza Viruses for Vaccines and Gene Therapy |
10/10/2013 | US20130267025 Partial Region Polypeptide of REIC/Dkk-3 Protein |
10/10/2013 | US20130267024 Nucleic acids and corresponding proteins entitled 282p1g3 useful in treatment and detection of cancer |
10/10/2013 | US20130267023 Multiple Inducible Gene Regulation System |
10/10/2013 | US20130267022 Therapeutic Inhibitors of PAI-1 Function Methods of Their Use |
10/10/2013 | US20130267013 Methods for isolation, use and analysis of ferritin |
10/10/2013 | US20130266972 Method of detecting protein losing enteropathy in animals |
10/10/2013 | US20130266961 Diagnosis and risk stratification by means of the novel marker ct-proadm |
10/10/2013 | US20130266607 Cholera Toxin Chimera and its Use as a Staph Vaccine |
10/10/2013 | US20130266606 Polyvalent chimeric ospc vaccinogen and diagnostic antigen |
10/10/2013 | US20130266605 Peptide inhibitors of cd40l signaling and uses therefor |
10/10/2013 | US20130266601 Mycoplasma Hyopneumoniae Vaccine |
10/10/2013 | US20130266600 Functional Mutations In Respiratory Syncytial Virus |
10/10/2013 | US20130266598 Identification, Optimization And Use Of Cryptic HLA-B7 Epitopes For Immunotherapy |
10/10/2013 | US20130266583 Clostridium difficile antigens |
10/10/2013 | US20130266581 Anti-vegf antibodies |
10/10/2013 | US20130266571 Three-dimensional structure of complement receptor type 2 and uses thereof |
10/10/2013 | US20130266553 Albumin Fusion Proteins |
10/10/2013 | US20130266519 Targeting vector-phospholipid conjugates |
10/10/2013 | DE102012102998A1 New polymer comprising two substances that bind to amyloid-beta-oligomers, useful for treating Alzheimer's disease, Parkinson's disease, Creutzfeldt Jakob disease or diabetes |
10/09/2013 | EP2647721A1 Peptide with safer secondary structure, peptide library, and production methods for same |
10/09/2013 | EP2647647A2 Thiopeptide precursor protein, gene encoding it and uses thereof |
10/09/2013 | EP2647646A1 Nucleic acid sequences and peptides/proteins of the FT family providing flower-repressing properties in tobacco and transgenic plants transformed therewith |
10/09/2013 | EP2647645A1 Recombinant proteins of Parapoxvirus ovis and pharmaceutical compositions therefrom |
10/09/2013 | EP2646552A1 Muteins of human lipocalin 2 with affinity for ctla-4 |
10/09/2013 | EP2646472A1 Covalently dimerized bivalent binding agents |
10/09/2013 | EP2646465A1 Generation of multifunctional and multivalent polypeptide complexes with collagen xviii trimerization domain |
10/09/2013 | EP2646464A1 Anticancer fusion protein |
10/09/2013 | EP2646463A1 Novel receptor-ligand interaction and uses thereof |
10/09/2013 | EP2646462A2 Methods and compositions for monitoring phagocytic activity |
10/09/2013 | EP2646461A2 VARIANTS OF igNAR |